Synergistic effect of cannabidiol with dasatinib on lung cancer by SRC/PI3K/AKT signal pathway

Synergistic effect of cannabidiol with dasatinib on lung cancer by SRC/PI3K/AKT signal pathway

Dasatinib-related resistance frequently occurs and may lead to the failure of chemotherapy; thus, dose interruptions are necessary. Cannabidiol (CBD) has potential for integration with orthodox cancer care. In this study, we explored the combination effect of CBD and dasatinib on A549 cells. CBD in...

Full description

Bibliographic Details
Main Authors:	Qianqian Ye, Changqin Gui, Di Jin, Jiazhen Zhang, Jing Zhang, Na Ma, Li Xu
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Biomedicine & Pharmacotherapy
Subjects:	Lung cancer Dasatinib Cannabidiol Synergistic effect Apoptosis SRC/PI3K/AKT pathway
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332224003299

Similar Items

Monitoring Src status after dasatinib treatment in HER2+ breast cancer with 89Zr-trastuzumab PET imaging
by: Brooke N. McKnight, et al.
Published: (2018-10-01)

Augmentation of the anticancer activity of CYT997 in human prostate cancer by inhibiting Src activity
by: Yong Teng, et al.
Published: (2017-06-01)

Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway
by: Robert A. Barclay, et al.
Published: (2020-06-01)

Sophoridine Counteracts Obesity via Src-Mediated Inhibition of VEGFR Expression and PI3K/AKT Phosphorylation
by: Jingchun Sun, et al.
Published: (2024-01-01)

Dasatinib and Trametinib Promote Anti-Tumor Metabolic Activity
by: Eric L. Bolf, et al.
Published: (2023-05-01)

Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma
by: Liwei Lang, et al.
Published: (2019-12-01)

Structure and Characterization of a Covalent Inhibitor of Src Kinase
by: Deepak Gurbani, et al.
Published: (2020-05-01)

Dasatinib reverses drug resistance by downregulating MDR1 and Survivin in Burkitt lymphoma cells
by: Mitsuki Tabata, et al.
Published: (2020-03-01)

A Phase I Trial of Dasatinib and Osimertinib in TKI Naïve Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer
by: Chul Kim, et al.
Published: (2021-09-01)

Treatment of Recurrent Intracranial Hemangiopericytoma with SRC-Related Tyrosine Kinase Targeted Therapy: A Case Report
by: Katherine B. Peters, et al.
Published: (2010-04-01)

Dasatinib suppresses particulate-induced pyroptosis and acute lung inflammation
by: Yixi Pan, et al.
Published: (2023-08-01)

Inhibition of Oncogenic Src Ameliorates Silica-Induced Pulmonary Fibrosis via PI3K/AKT Pathway
by: Xiaohui Hao, et al.
Published: (2023-01-01)

Cannabidiol‐mediated RISK PI3K/AKT and MAPK/ERK pathways decreasing reperfusion myocardial damage
by: Antonio Franco‐Vadillo, et al.
Published: (2021-08-01)

Regulation of the prometastatic neuregulin–MMP13 axis by SRC family kinases: therapeutic implications
by: Ana Orive‐Ramos, et al.
Published: (2017-12-01)

TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis
by: Guo-sheng Zhao, et al.
Published: (2018-08-01)

Direct effect of dasatinib on signal transduction pathways associated with a rapid mobilization of cytotoxic lymphocytes
by: Noriyoshi Iriyama, et al.
Published: (2016-11-01)

Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer
by: Ragini Singh, et al.
Published: (2022-11-01)

PI3K/AKT and STAT3 pathways mediate the neuroprotective effect of dasatinib from acute cerebral injury in endotoxemic mice
by: Ammar Rasoul Mohammad, et al.
Published: (2024-01-01)

Sulforaphane Regulates eNOS Activation and NO Production via Src-Mediated PI3K/Akt Signaling in Human Endothelial EA.hy926 Cells
by: Ying Zhang, et al.
Published: (2022-08-01)

Src Tyrosine Kinase Inhibitors: New Perspectives on Their Immune, Antiviral, and Senotherapeutic Potential
by: José Rivera-Torres, et al.
Published: (2019-09-01)

DT-13 Ameliorates TNF-α-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling Pathway
by: Yuanyuan Zhang, et al.
Published: (2017-08-01)

Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway
by: Li ZQ, et al.
Published: (2023-11-01)

SRC inhibition prevents P-cadherin mediated signaling and function in basal-like breast cancer cells
by: Ana Sofia Ribeiro, et al.
Published: (2018-11-01)

CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6/Src/PI3K/Akt pathway
by: Xiaojia Huang, et al.
Published: (2022-06-01)

The synergistic effect of 2,3,5,4′-Tetrahydroxystilbene-2-O-β-D-glucoside combined with Adriamycin on MCF-7 breast cancer cells
by: Shen JF, et al.
Published: (2018-11-01)

CRF1 Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase Mechanisms
by: G. Karina Parra-Mercado, et al.
Published: (2019-12-01)

Cetuximab PET delineated changes in cellular distribution of EGFR upon dasatinib treatment in triple negative breast cancer
by: Brooke N. McKnight, et al.
Published: (2020-04-01)

Statin-Sensitive Akt1/Src/Caveolin-1 Signaling Enhances Oxidative Stress Resistance in Rhabdomyosarcoma
by: Silvia Codenotti, et al.
Published: (2024-02-01)

Dasatinib enhances curcumin-induced cytotoxicity, apoptosis and protective autophagy in human schwannoma cells HEI-193: The role of Akt/mTOR/p70S6K signalling pathway
by: Pang Pengfei, et al.
Published: (2022-09-01)

A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
by: Nicolas Bradt, et al.
Published: (2022-10-01)

Safety and Activity of the Combination of Ceritinib and Dasatinib in Osteosarcoma
by: Olaf Beck, et al.
Published: (2020-03-01)

Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
by: Ke Lin, et al.
Published: (2020-02-01)

Dasatinib-Related Chylothorax
by: Yen Min Huang, et al.
Published: (2015-02-01)

Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling Pathway
by: Xiaozhong Liao, et al.
Published: (2020-09-01)

Baicalein alleviates TNF-α-induced apoptosis of human nucleus pulposus cells through PI3K/AKT signaling pathway
by: Yang Liu, et al.
Published: (2023-04-01)

Dasatinib targets c-Src kinase in cardiotoxicity
by: Manar Elmadani, et al.
Published: (2023-01-01)

An unexpected and devastating adverse event of dasatinib: Rhabdomyolysis
by: Burak Uz, et al.
Published: (2016-01-01)

RETRACTED: Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
by: Li-Mei Wu, et al.
Published: (2021-02-01)

Overexpression of α2 subunit of Na-K-ATPase suppresses invasion and migration of human breast cancer cells in vitro by inhibiting the Src/PI3K/Akt signaling pathway
by: QIN Yi, et al.
Published: (2019-11-01)

Dasatinib-induced pleural effusion: Chylothorax, an option to consider
by: Lucia Ferreiro, et al.
Published: (2016-01-01)